Top compounds associated with response to CTC-260F20.3


Feature Type Standardized
Nominal ANOVA
mRNA B02 CTRPv2 pan-cancer AAC -0.0004 1
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.00024 1
mRNA tivantinib CTRPv2 pan-cancer AAC 0.00014 1
mRNA brivanib CTRPv2 pan-cancer AAC 8.6e-05 1
Download CSV